» Articles » PMID: 25608532

Identification of Tyr Residues That Enhance Folate Substrate Binding and Constrain Oscillation of the Proton-coupled Folate Transporter (PCFT-SLC46A1)

Overview
Specialties Cell Biology
Physiology
Date 2015 Jan 23
PMID 25608532
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The proton-coupled folate transporter (PCFT) mediates intestinal folate absorption and transport of folates across the choroid plexus. This study focuses on the role of Tyr residues in PCFT function. The substituted Cys-accessibility method identified four Tyr residues (Y291, Y362, Y315, and Y414) that are accessible to the extracellular compartment; three of these (Y291, Y362, and Y315) are located within or near the folate binding pocket. When the Tyr residues were replaced with Cys or Ala, these mutants showed similar (up to 6-fold) increases in influx Vmax and Kt/Ki for [(3)H]methotrexate and [(3)H]pemetrexed. When the Tyr residues were replaced with Phe, these changes were moderated or absent. When Y315A PCFT was used as representative of the mutants and [(3)H]pemetrexed as the transport substrate, this substitution did not increase the efflux rate constant. Furthermore, neither influx nor efflux mediated by Y315A PCFT was transstimulated by the presence of substrate in the opposite compartment; however, substantial bidirectional transstimulation of transport was mediated by wild-type PCFT. This resulted in a threefold greater efflux rate constant for cells that express wild-type PCFT than for cells that express Y315 PCFT under exchange conditions. These data suggest that these Tyr residues, possibly through their rigid side chains, secure the carrier in a high-affinity state for its folate substrates. However, this may be achieved at the expense of constraining the carrier's mobility, thereby decreasing the rate at which the protein oscillates between its conformational states. The Vmax generated by these Tyr mutants may be so rapid that further augmentation during transstimulation may not be possible.

Citing Articles

The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of Tyrosine Kinase Inhibitors.

Xiu F, Rausch M, Gai Z, Su S, Wang S, Visentin M Int J Mol Sci. 2023; 24(3).

PMID: 36768423 PMC: 9917293. DOI: 10.3390/ijms24032101.


Biology and therapeutic applications of the proton-coupled folate transporter.

Matherly L, Schneider M, Gangjee A, Hou Z Expert Opin Drug Metab Toxicol. 2022; 18(10):695-706.

PMID: 36239195 PMC: 9637735. DOI: 10.1080/17425255.2022.2136071.


The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanism.

Hou Z, Gangjee A, Matherly L FASEB J. 2022; 36(2):e22164.

PMID: 35061292 PMC: 8978580. DOI: 10.1096/fj.202101704R.


A proton-coupled folate transporter mutation causing hereditary folate malabsorption locks the protein in an inward-open conformation.

Zhan H, Najmi M, Lin K, Aluri S, Fiser A, Goldman I J Biol Chem. 2020; 295(46):15650-15661.

PMID: 32893190 PMC: 7667981. DOI: 10.1074/jbc.RA120.014757.


Substitutions that lock and unlock the proton-coupled folate transporter (PCFT-SLC46A1) in an inward-open conformation.

Aluri S, Zhao R, Lin K, Shin D, Fiser A, Goldman I J Biol Chem. 2019; 294(18):7245-7258.

PMID: 30858177 PMC: 6509503. DOI: 10.1074/jbc.RA118.005533.


References
1.
Granseth E, von Heijne G, Elofsson A . A study of the membrane-water interface region of membrane proteins. J Mol Biol. 2005; 346(1):377-85. DOI: 10.1016/j.jmb.2004.11.036. View

2.
Zhao R, Babani S, Gao F, Liu L, Goldman I . The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Clin Cancer Res. 2000; 6(9):3687-95. View

3.
Smirnova I, Kaback H . A mutation in the lactose permease of Escherichia coli that decreases conformational flexibility and increases protein stability. Biochemistry. 2003; 42(10):3025-31. DOI: 10.1021/bi027329c. View

4.
Chenna R, Sugawara H, Koike T, Lopez R, Gibson T, Higgins D . Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 2003; 31(13):3497-500. PMC: 168907. DOI: 10.1093/nar/gkg500. View

5.
Diop-Bove N, Wu J, Zhao R, Locker J, Goldman I . Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant HeLa cell line. Mol Cancer Ther. 2009; 8(8):2424-31. PMC: 2735101. DOI: 10.1158/1535-7163.MCT-08-0938. View